Radiosynthesis and evaluation of [18F]FMTP, a COX-2 PET ligand

被引:8
|
作者
Kumar, J. S. Dileep [1 ]
Prabhakaran, Jaya [1 ,2 ]
Molotkov, Andrei [3 ]
Sattiraju, Anirudh [3 ]
Kim, Jongho [3 ]
Doubrovin, Mikhail [3 ]
Mann, J. John [1 ,2 ,3 ]
Mintz, Akiva [3 ]
机构
[1] New York State Psychiat Inst & Hosp, Mol Imaging & Neuropathol Div, New York, NY USA
[2] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA
[3] Columbia Univ, Dept Radiol, Med Ctr, New York, NY USA
关键词
PET; COX-2; Radiotracer; Inflammation; Brain; IN-VIVO EVALUATION; PROSTAGLANDIN ENDOPEROXIDE SYNTHASE; CYCLOOXYGENASE-2; COX-2; RADIOLIGANDS; RADIOTRACER; INHIBITORS; ENZYME; BRAIN; NEUROINFLAMMATION; OVEREXPRESSION;
D O I
10.1007/s43440-020-00124-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background The upregulation of cyclooxygenase-2 (COX-2) is involved in neuroinflammation associated with many neurological diseases as well as cancers of the brain. Outside the brain, inflammation and COX-2 induction contribute to the pathogenesis of pain, arthritis, acute allograft rejection, and in response to infections, tumors, autoimmune disorders, and injuries. Herein, we report the radiochemical synthesis and evaluation of [F-18]6-fluoro-2-(4-(methylsulfonyl)phenyl)-N-(thiophen-2-ylmethyl)pyrimidin-4-amine ([F-18]FMTP), a high-affinity COX-2 inhibitor, by cell uptake and PET imaging studies. Methods The radiochemical synthesis of [F-18]FMTP was optimized using chlorine to fluorine displacement method, by reacting [F-18]fluoride/K222/K(2)CO(3)with the precursor molecule. Cellular uptake studies of [F-18]FMTP was performed in COX-2 positive BxPC3 and COX-2 negative PANC-1 cell lines with unlabeled FMTP as well as celecoxib to define specific binding agents. Dynamic microPET image acquisitionwas performed in anesthetized nude mice (n = 3), lipopolysaccharide (LPS) induced neuroinflammation mice (n = 4), and phosphate-buffered saline (PBS) administered control mice (n = 4) using a Trifoil microPET/CT for a scan period of 60 min. Results A twofold higher binding of [F-18]FMTP was found in COX-2 positive BxPC3 cells compared with COX-2 negative PANC-1 cells. The radioligand did not show specific binding to COX-2 negative PANC-1 cells. MicroPET imaging in wild-type mice indicated blood-brain barrier (BBB) penetration and fast washout of [F-18]FMTP in the brain, likely due to the low constitutive COX-2 expression in the normal brain. In contrast, a similar to twofold higher uptake of the radioligand was found in LPS-induced mice brain than PBS treated control mice. Conclusions Specific binding to COX-2 in BxPC3 cell lines, BBB permeability, and increased brain uptake in neuroinflammation mice qualifies [F-18]FMTP as a potential PET tracer for studying inflammation.
引用
收藏
页码:1433 / 1440
页数:8
相关论文
共 50 条
  • [1] Radiosynthesis and evaluation of [18F]FMTP, a COX-2 PET ligand
    J. S. Dileep Kumar
    Jaya Prabhakaran
    Andrei Molotkov
    Anirudh Sattiraju
    Jongho Kim
    Mikhail Doubrovin
    J. John Mann
    Akiva Mintz
    Pharmacological Reports, 2020, 72 : 1433 - 1440
  • [2] Radiosynthesis and evaluation of [18F]MTP: A potential COX-2 PET ligand
    Prabhakaran, Jaya
    Kumar, Dileep
    Simpson, Norman
    Kim, Jongho
    Castrillon, John
    Molotkov, Andrei
    Doubrovin, Mikhail
    Mann, J.
    Mintz, Akiva
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [3] Radiosynthesis and Biological Evaluation of [18F]Triacoxib: A New Radiotracer for PET Imaging of COX-2
    Litchfield, Marcus
    Wuest, Melinda
    Glubrecht, Darryl
    Wuest, Frank
    MOLECULAR PHARMACEUTICS, 2020, 17 (01) : 251 - 261
  • [4] Radiosynthesis of [18F]ATPFU: a potential PET ligand for mTOR
    Majo, Vattoly J.
    Simpson, Norman R.
    Prabhakaran, Jaya
    Mann, J. John
    Kumar, J. S. Dileep
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2014, 57 (13): : 705 - 709
  • [5] Radiosynthesis and preliminary evaluation of an 18F-labeled diarylpyrrole-based PET tracer targeting COX-2
    Li, Yuying
    Jia, Jianhua
    Miao, Wengjun
    Xia, Zhu
    Yi, Lan
    Yang, Meixian
    Chen, Yi
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S63 - S64
  • [6] Radiosynthesis and evaluation of 18F-labeled methylsulfonylpyrimidin-4-amine derivates as COX-2 PET ligands
    Kumar, Dileep
    Prabhakaran, Jaya
    Molotkov, Andrei
    Kim, Jongho
    Castrillon, John
    Doubrovin, Mikhail
    Mann, J.
    Mintz, Akiva
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [7] Synthesis and in vivo evaluation of [18F]-celecoxib:: A potential PET marker for COX-2 expression.
    Kumar, JSD
    Prabhakaran, J
    Parsey, RV
    Underwood, MD
    Simpson, NR
    Majo, VJ
    van Heertum, R
    Mann, JJ
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 314P - 314P
  • [8] Radiosynthesis and evaluation of [18F]labeled microtubule targeted PET ligands
    Kumar, Dileep
    Prabhakaran, Jaya
    Molotkov, Andrei
    Kim, Jongho
    Castrillon, John
    Mann, J.
    Mintz, Akiva
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [9] Radiosynthesis, in vitro validation, and in vivo evaluation of 18F-labeled COX-1 and COX-2 inhibitors
    McCarthy, TJ
    Sheriff, AU
    Graneto, MJ
    Talley, JJ
    Welch, MJ
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (01) : 117 - 124
  • [10] Biological evaluation of 2′-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET
    Mitterhauser, M
    Wadsak, W
    Wabnegger, L
    Mien, LK
    Tögel, S
    Langer, O
    Sieghart, W
    Viernstein, H
    Kletter, K
    Dudczak, R
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (02) : 291 - 295